» Articles » PMID: 33904528

Incidence, Risk Factors, Clinical Characteristics and Outcomes of Deep Venous Thrombosis in Patients with COVID-19 Attending the Emergency Department: Results of the UMC-19-S8

Abstract

Background And Importance: A higher incidence of venous thromboembolism [both pulmonary embolism and deep vein thrombosis (DVT)] in patients with coronavirus disease 2019 (COVID-19) has been described. But little is known about the true frequency of DVT in patients who attend emergency department (ED) and are diagnosed with COVID-19.

Objective: We investigated the incidence, risk factors, clinical characteristics and outcomes of DVT in patients with COVID-19 attending the ED before hospitalization.

Methods: We retrospectively reviewed all COVID patients diagnosed with DVT in 62 Spanish EDs (20% of Spanish EDs, case group) during the first 2 months of the COVID-19 outbreak. We compared DVT-COVID-19 patients with COVID-19 without DVT patients (control group). Relative frequencies of DVT were estimated in COVID and non-COVID patients visiting the ED and annual standardized incidences were estimated for both populations. Sixty-three patient characteristics and four outcomes were compared between cases and controls.

Results: We identified 112 DVT in 74 814 patients with COVID-19 attending the ED [1.50‰; 95% confidence interval (CI), 1.23-1.80‰]. This relative frequency was similar than that observed in non-COVID patients [2109/1 388 879; 1.52‰; 95% CI, 1.45-1.69‰; odds ratio (OR) = 0.98 [0.82-1.19]. Standardized incidence of DVT was higher in COVID patients (98,38 versus 42,93/100,000/year; OR, 2.20; 95% CI, 2.03-2.38). In COVID patients, the clinical characteristics associated with a higher risk of presenting DVT were older age and having a history of venous thromboembolism, recent surgery/immobilization and hypertension; chest pain and desaturation at ED arrival and some analytical disturbances were also more frequently seen, d-dimer >5000 ng/mL being the strongest. After adjustment for age and sex, hospitalization, ICU admission and prolonged hospitalization were more frequent in cases than controls, whereas mortality was similar (OR, 1.37; 95% CI, 0.77-2.45).

Conclusions: DVT was an unusual form of COVID presentation in COVID patients but was associated with a worse prognosis.

Citing Articles

Predictors of venous thromboembolic events in hospitalized patients with COVID-19.

Scimeca G, Krishnathasan D, Rashedi S, Lan Z, Sato A, Hamade N J Thromb Thrombolysis. 2025; .

PMID: 40064840 DOI: 10.1007/s11239-025-03078-2.


Thromboembolic Disease and COVID-19: Experience of a University and Emergency Hospital During the Pandemic.

Stefan M, Magda L, Rimbas R, Vinereanu D Cureus. 2024; 16(9):e68767.

PMID: 39371718 PMC: 11456164. DOI: 10.7759/cureus.68767.


Clinical characteristics of COVID-19 associated vasculopathic diseases.

Greistorfer T, Jud P Thromb J. 2023; 21(1):61.

PMID: 37231476 PMC: 10209947. DOI: 10.1186/s12959-023-00504-4.


Clinical characteristics and laboratory parameters of deep venous thrombosis after SARS-CoV-2 infection in a non-hospital setting - a single-center retrospective study.

Sablic S, Lovric Kojundzic S, Budimir Mrsic D, Dragicevic D, Marinovic Guic M, Kraljevic I Croat Med J. 2022; 63(5):448-452.

PMID: 36325669 PMC: 9648089.


Late-onset hematological complications post COVID-19: An emerging medical problem for the hematologist.

Korompoki E, Gavriatopoulou M, Fotiou D, Ntanasis-Stathopoulos I, Dimopoulos M, Terpos E Am J Hematol. 2021; 97(1):119-128.

PMID: 34687462 PMC: 8646944. DOI: 10.1002/ajh.26384.